Rachel Tétaz

664 total citations
12 papers, 203 citations indexed

About

Rachel Tétaz is a scholar working on Transplantation, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rachel Tétaz has authored 12 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Rachel Tétaz's work include Renal Transplantation Outcomes and Treatments (6 papers), Renal and Vascular Pathologies (4 papers) and Renal Diseases and Glomerulopathies (2 papers). Rachel Tétaz is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Renal and Vascular Pathologies (4 papers) and Renal Diseases and Glomerulopathies (2 papers). Rachel Tétaz collaborates with scholars based in France, Switzerland and China. Rachel Tétaz's co-authors include Laurence Dubel, Magali Giral, Georges‐Philippe Pageaux, Sébastien Dharancy, François Bayle, Bénédicte Janbon, Thomas Jouvé, Paolo Malvezzi, Thierry Berney and N. Pinel and has published in prestigious journals such as Diabetes Care, Transplant International and Clinical Transplantation.

In The Last Decade

Rachel Tétaz

11 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Tétaz France	5	131	105	44	42	31	12	203
J.-P Squifflet Belgium	5	168 1.3×	198 1.9×	12 0.3×	41 1.0×	60 1.9×	12	305
Jørn Petter Lindahl Norway	9	197 1.5×	211 2.0×	44 1.0×	28 0.7×	20 0.6×	17	279
Mary Beth Drangstveit United States	9	340 2.6×	291 2.8×	37 0.8×	48 1.1×	29 0.9×	10	376
Rossella Gioco Italy	9	67 0.5×	49 0.5×	34 0.8×	12 0.3×	5 0.2×	12	148
Jan Dmitrewski United Kingdom	8	136 1.0×	83 0.8×	9 0.2×	20 0.5×	18 0.6×	15	224
Lissa Pipeleers Belgium	7	34 0.3×	43 0.4×	15 0.3×	15 0.4×	8 0.3×	14	153
L. Olson United States	12	335 2.6×	122 1.2×	99 2.3×	113 2.7×	8 0.3×	33	456
J Östman Sweden	10	330 2.5×	173 1.6×	124 2.8×	174 4.1×	10 0.3×	25	423
Helen Lambeth United States	3	72 0.5×	23 0.2×	151 3.4×	116 2.8×	6 0.2×	3	257
Facundo Villamil Argentina	6	76 0.6×	46 0.4×	23 0.5×	3 0.1×	6 0.2×	26	234

Countries citing papers authored by Rachel Tétaz

Since Specialization

Citations

This map shows the geographic impact of Rachel Tétaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Tétaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Tétaz more than expected).

Fields of papers citing papers by Rachel Tétaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Tétaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Tétaz. The network helps show where Rachel Tétaz may publish in the future.

Co-authorship network of co-authors of Rachel Tétaz

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Tétaz. A scholar is included among the top collaborators of Rachel Tétaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Tétaz. Rachel Tétaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Noble, Johan, et al.. (2021). Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies. Case Reports in Oncology. 14(1). 676–680. 1 indexed citations

Malvezzi, Paolo, et al.. (2021). A Case of <b><i>Pneumocystis jirovecii</i></b> Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection. Case Reports in Nephrology and Dialysis. 11(1). 10–15. 1 indexed citations

Jouvé, Thomas, Matthieu Roustit, N. Terrier, et al.. (2020). Predonation Single Kidney Glomerular Filtration Rate in Living Kidney Transplantation to Predict Graft Function and Donor Functional Gain. Transplantation Proceedings. 52(3). 712–721. 2 indexed citations

Jouvé, Thomas, Bénédicte Janbon, N. Pinel, et al.. (2019). Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant Patients. Experimental and Clinical Transplantation. 17(4). 483–489. 4 indexed citations

Tétaz, Rachel, et al.. (2019). Utilisation concomitante du nivolumab et d’immunosuppresseurs chez un patient greffé rénal. Revue des Maladies Respiratoires. 36(9). 1064–1068. 4 indexed citations

Trocmé, Candice, Sabrina Vergnaud, Bénédicte Janbon, et al.. (2019). Early Prediction of Graft Outcomes After Kidney Transplantation From Donors After Circulatory Death: Biomarkers and Transplantation Characteristics. Transplantation Proceedings. 51(10). 3234–3243. 2 indexed citations

Jouvé, Thomas, et al.. (2019). Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series. Case Reports in Nephrology. 2019. 1–4.

Terrier, N., Jean‐Jacques Rambeaud, Jean‐Alexandre Long, et al.. (2018). Aortic bypass surgery for asymptomatic patients awaiting a kidney transplant: A word of caution. Clinical Transplantation. 32(4). e13218–e13218. 11 indexed citations

Lablanche, Sandrine, Sophie Borot, Anne Wojtusciszyn, et al.. (2015). Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network. Diabetes Care. 38(9). 1714–1722. 77 indexed citations

10.

Tétaz, Rachel, Matthieu Roustit, Paolo Malvezzi, et al.. (2014). Conversion to mammalian target of rapamycin inhibitors increases risk ofde novodonor-specific antibodies. Transplant International. 27(8). 775–783. 43 indexed citations

11.

Bouillet, Laurence, et al.. (2014). Infarctus rénal chez des consommateurs de cannabis. La Revue de Médecine Interne. 35. A134–A134. 1 indexed citations

12.

Dharancy, Sébastien, et al.. (2012). Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clinical Transplantation. 26(3). E293–9. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact